2014 Annual Meeting | 3HC.011 - Infections of the Nervous System II: Advanced and Emerging Infections

Date Monday 04/28/14

Time 01:00 PM - 05:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Half-Day Course

Director(s) Joseph R. Zunt, MD

Topic(s)

Learning Objectives Participants should become familiar with current diagnostic algorithms and treatment recommendations for a wide variety of advanced and emerging infections affecting the central nervous system.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Recommended Audience Trainee, General Neurologist, Specialist Neurologist

Teaching Styles Case-based, Didactic, Interactive

Event Timeline
01:00 PM - 01:55 PM		Updates in NeuroHIV Michael R. Wilson, MD, FAAN
01:55 PM - 02:50 PM		CNS Infections in Patients Receiving Cancer Therapy Amy A. Pruitt, MD, FAAN
02:50 PM - 03:10 PM		Break
03:10 PM - 04:05 PM		Bacterial Toxin Diseases: Tetanus and Botulism Thomas P. Bleck, MD, FAAN
04:05 PM - 05:00 PM		The International Traveler with Neurologic Symptoms Joseph R. Zunt, MD

Faculty Disclosures
Joseph R. Zunt, MD	The institution of Dr. Zunt has received research support from NIH.
Michael R. Wilson, MD, FAAN	Dr. Wilson has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Delve Bio. Dr. Wilson has stock in Delve Bio. The institution of Dr. Wilson has received research support from Genentech / Roche. The institution of Dr. Wilson has received research support from NIH. The institution of Dr. Wilson has received research support from UCSF Weill Institute for Neurosciences. The institution of Dr. Wilson has received research support from Novartis. The institution of Dr. Wilson has received research support from National Multiple Sclerosis Society. The institution of Dr. Wilson has received research support from Fanconi Anemia Research Foundation. The institution of Dr. Wilson has received research support from Department of Defense. Dr. Wilson has received intellectual property interests from a discovery or technology relating to health care. Dr. Wilson has received intellectual property interests from a discovery or technology relating to health care. Dr. Wilson has received personal compensation in the range of $10,000-$49,999 for serving as a Expert Witness with US Dept of Justice.
Amy A. Pruitt, MD, FAAN	Dr. Pruitt has nothing to disclose.
Thomas P. Bleck, MD, FAAN	Dr. Bleck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Bleck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Marinus Pharmaceuticals. Dr. Bleck has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for iECURE. Dr. Bleck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acasti. Dr. Bleck has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Society of Critical Care Medicine. Dr. Bleck has received research support from NIH.